NIH-funded research R01 grant

Investigating a treatment for lymphedema using retinoic acid

Official title: Retinoic Acid Induced Lymphangiogenesis for Post-Surgical Lymphedema

Funded at Rutgers Biomedical and Health Sciences · NIH-11063577 · Data updated 2026-11-12

This study is looking at how a substance called 9-cis retinoic acid might help grow new lymphatic vessels to improve swelling and immune issues for people with lymphedema, especially those who have had cancer surgeries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startSeptember 1, 2021
Project endAugust 31, 2026
Funding year2024
Award (this year)$645,721
NIH project number7R01HL157626-04
Project IDNIH-11063577 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have developed lymphedema following cancer treatments, particularly those who have undergone lymph node dissection.

Less likely to help

Patients with lymphedema not related to surgical interventions or those with other underlying conditions affecting lymphatic function may not benefit from this research.

What this research studies

This research focuses on lymphedema, a condition that causes swelling and immune dysfunction after lymphatic injury, often following cancer surgeries. The study aims to explore how 9-cis retinoic acid can promote the growth of lymphatic vessels, potentially restoring normal lymphatic function. By using preclinical models, researchers will investigate the mechanisms behind this process and develop a framework for future clinical applications. The ultimate goal is to provide a new therapeutic option for patients suffering from lymphedema.

Why it matters

Potential benefit: If successful, this research could lead to a new treatment that alleviates the symptoms of lymphedema and improves patients' quality of life.

How similar studies have gone: Previous research has shown promising results with similar approaches in animal models, indicating potential for success in clinical applications.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Wong, Alex K. — Rutgers Biomedical and Health Sciences
  • Study coordinator: Wong, Alex K.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.